Teva Pharmaceuticals
TEVA
TEVA
551 hedge funds and large institutions have $10.5B invested in Teva Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 167 increasing their positions, 180 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
551
Holders Change
-5
Holders Change %
-0.9%
% of All Funds
12.3%
Holding in Top 10
17
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+21.43%
% of All Funds
0.38%
New
85
Increased
167
Reduced
180
Closed
82
Calls
$510M
Puts
$467M
Net Calls
+$42.8M
Net Calls Change
+$71.8M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$166M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$101M |
| 3 |
BC
Brahman Capital
New York
|
+$75.9M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$55.5M |
| 5 |
Renaissance Technologies
New York
|
+$53.5M |
Top Sellers
| 1 |
O
OppenheimerFunds
New York
|
-$91.2M |
| 2 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$51.8M |
| 3 |
Citigroup
New York
|
-$45.5M |
| 4 |
TA
Teachers Advisors
New York
|
-$39.3M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$34.9M |
